AstraZeneca expects COVID-19 vaccine capacity of 200M a month by April

 AstraZeneca expects to produce more than 100 million doses of its COVID-19 vaccine - developed with Oxford University - this month, ramping up to more than 200 million a month by April, Chief Executive Pascal Soriot said on Thursday.

Mene Pangalos, head of BioPharmaceuticals R&D at the British drugmaker earlier said the company expects much-anticipated data for the late-stage U.S. trial of its vaccine before the end of March.

A read-out on data is “only weeks away”, he said on a media call after release of the company’s 2020 results.

https://www.reuters.com/article/us-astrazeneca-results-vaccine/astrazeneca-expects-covid-19-vaccine-capacity-of-200-million-a-month-by-april-idUSKBN2AB117